Incidence of clinical neuropathy, abnormal NCSs, and confirmed clinical neuropathy at DCCT closeout and EDIC years 13–14 among subjects who did not fulfill the specific criterion for neuropathy at the preceding evaluation
| Variable . | DCCT baseline . | DCCT closeout . | EDIC years 13–14 . |
|---|---|---|---|
| Clinical neuropathy | |||
| INT | 57/600 (10) | 57/533 (11)† | 145/505 (29) |
| CONV | 48/581 (8) | 96/526 (18) | 154/448 (34) |
| Abnormal NCSs | |||
| INT | 185/601 (31) | 73/410 (18)† | 195/430 (45) |
| CONV | 196/582 (34) | 137/382 (36) | 151/290 (52) |
| Confirmed clinical neuropathy | |||
| INT | 39/600 (7) | 32/551 (6)† | 117/541 (22) |
| CONV | 31/581 (5) | 75/543 (14) | 136/479 (28)‡ |
| Variable . | DCCT baseline . | DCCT closeout . | EDIC years 13–14 . |
|---|---|---|---|
| Clinical neuropathy | |||
| INT | 57/600 (10) | 57/533 (11)† | 145/505 (29) |
| CONV | 48/581 (8) | 96/526 (18) | 154/448 (34) |
| Abnormal NCSs | |||
| INT | 185/601 (31) | 73/410 (18)† | 195/430 (45) |
| CONV | 196/582 (34) | 137/382 (36) | 151/290 (52) |
| Confirmed clinical neuropathy | |||
| INT | 39/600 (7) | 32/551 (6)† | 117/541 (22) |
| CONV | 31/581 (5) | 75/543 (14) | 136/479 (28)‡ |
Data are n (%).
†P < 0.001 former intensive treatment group (INT) vs. former conventional treatment group (CONV).
‡P = 0.125.